DR. VERNON DEAN BOWMAN MD NPI 1053311068

NPI Details

DR. Vernon Dean Bowman, MD is a family medicine in Ashdown, AR with 24 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Vernon Dean Bowman, MD NPI is 1053311068. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Graduation Year:2002

The provider's business location address is:

146 HWY 32-2A
ASHDOWN, AR
ZIP 71822
Phone: (870) 898-5525

The NPI 1053311068 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Extended patient service without direct patient contact, first hour (HCPCS:99358)
• Established patient home visit, typically 40 minutes (HCPCS:99349)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient home visit, typically 1 hour (HCPCS:99350)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow (HCPCS:G0181)
• Established patient home visit, typically 25 minutes (HCPCS:99348)
• Follow-up nursing facility visit per day, typically 10 minutes (HCPCS:99307)
• New patient home visit, typically 1 hour (HCPCS:99344)
• Urinalysis, manual test (HCPCS:81002)
• New patient home visit, typically 75 minutes (HCPCS:99345)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Assessment of emotional or behavioral problems (HCPCS:96127)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• New patient home visit, typically 45 minutes (HCPCS:99343)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Removal of impacted ear wax (HCPCS:69210)
• Administration of vaccine (HCPCS:90471)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital duri (HCPCS:M0241)
• Injection, casirivimab and imdevimab, 600 mg (HCPCS:Q0240)
• Established patient home visit, typically 15 minutes (HCPCS:99347)

The enumeration date for this NPI number is 8/1/2005 and was last updated on 4/9/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.